)

Genedrive (GDR) investor relations material
Genedrive Trading Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Financial performance and outlook
Total income for FY25 reached approximately £1m, doubling from FY24 and showing strong H2 momentum with £0.65m generated in the second half.
Overheads remained stable year-on-year, with a strategic shift towards focused commercial activities.
Early FY26 income visibility stands at around £0.6m, supported by ongoing and upcoming UK healthcare initiatives.
International sales are gaining traction, particularly in Europe and the Middle East, with further growth expected.
Cash balances are approximately £700k, with active assessment of financing options for additional working capital.
Strategic and regulatory developments
NICE Early Value Assessment completion and submission is expected to drive wider UK implementation.
Scotland's phased national implementation and Manchester NHS Foundation Trust's genotyping programme are set to begin in FY26.
Anticipated FDA 510(k) submission for the CYP2C19 ID Kit in early 2026, with a 3-4 month review process.
UK healthcare reforms will introduce mandated NHS funding for MedTech, diagnostics, and digital products by April 2026.
The new 'innovator passport' will facilitate rapid adoption of robustly assessed technologies across NHS organisations.
Product and market positioning
Two CE-IVD certified, NICE-recommended rapid genetic testing products address critical needs in neonatology, neurology, and cardiology.
The MT-RNR1 ID Kit enables antibiotic decisions in neonatal care within 26 minutes, while the CYP2C19 ID Kit guides antiplatelet therapy in stroke patients in 70 minutes.
Both products are single-use, ambient-stable cartridges, eliminating cold chain requirements.
Initial commercial traction is evident in Italy, Netherlands, UAE, Bahrain, Kuwait, Saudi Arabia, and Qatar.
Commercial strategy focuses on in-market sales, geographic expansion, and strategic M&A.
Next Genedrive earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage